- Home
- GSBC vs IOVA Comparison
GSBC vs IOVA Comparison
Compare GSBC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- IOVA
- Stock Information
- Founded
- GSBC 1923
- IOVA 2007
- Country
- GSBC United States
- IOVA United States
- Employees
- GSBC N/A
- IOVA N/A
- Industry
- GSBC Major Banks
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GSBC Finance
- IOVA Health Care
- Exchange
- GSBC Nasdaq
- IOVA Nasdaq
- Market Cap
- GSBC 676.3M
- IOVA 975.1M
- IPO Year
- GSBC N/A
- IOVA N/A
- Fundamental
- Price
- GSBC $62.78
- IOVA $2.29
- Analyst Decision
- GSBC Hold
- IOVA Buy
- Analyst Count
- GSBC 2
- IOVA 11
- Target Price
- GSBC $60.50
- IOVA $11.90
- AVG Volume (30 Days)
- GSBC 31.5K
- IOVA 10.8M
- Earning Date
- GSBC 10-15-2025
- IOVA 11-06-2025
- Dividend Yield
- GSBC 2.55%
- IOVA N/A
- EPS Growth
- GSBC 17.24
- IOVA N/A
- EPS
- GSBC 5.86
- IOVA N/A
- Revenue
- GSBC $224,299,000.00
- IOVA $241,525,000.00
- Revenue This Year
- GSBC N/A
- IOVA $67.40
- Revenue Next Year
- GSBC N/A
- IOVA $56.32
- P/E Ratio
- GSBC $10.70
- IOVA N/A
- Revenue Growth
- GSBC 4.82
- IOVA 636.99
- 52 Week Low
- GSBC $47.58
- IOVA $1.64
- 52 Week High
- GSBC $68.02
- IOVA $12.51
- Technical
- Relative Strength Index (RSI)
- GSBC 53.80
- IOVA 52.07
- Support Level
- GSBC $62.76
- IOVA $2.27
- Resistance Level
- GSBC $63.81
- IOVA $2.46
- Average True Range (ATR)
- GSBC 0.76
- IOVA 0.12
- MACD
- GSBC -3.59
- IOVA -0.13
- Stochastic Oscillator
- GSBC 96.04
- IOVA 91.60
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.